Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D06LYG
|
||||
Former ID |
DAP000511
|
||||
Drug Name |
Prilocaine
|
||||
Synonyms |
Citanest; Prilocaina; Prilocainum; Propitocaine; Prilocaine [USAN]; Prilocaine base; Astra 1512; Astra 1515; L 67; Citanest (TN); Prilocaina [INN-Spanish]; Prilocainum [INN-Latin]; Propitocaine (JAN); Prilocaine (USP/INN); O-Methyl-2-propylaminopropionanilide; O-Methyl-alpha-propylaminopropionanilide; Alpha-n-Propylamino-2-methylpropionanilide; N-[2-Methylphenyl]-2-[propylamino]propanamide; N-(2-methylphenyl)-N2-propylalaninamide; N-(2-Methylphenyl)-2-(propylamino)propanamide; N-(2-methylphenyl)-N(2)-propylalaninamide; Propanamide, N-(2-methylphenyl)-2-(propylamino)-(9CI); 2-(Propylamino)-o-propionotoluidide; 2-Methyl-.alpha.-propylaminopropionanilide; 2-Methyl-alpha-propylaminopropionanilide
|
||||
Drug Type |
Small molecular drug
|
||||
Therapeutic Class |
Anesthetics
|
||||
Company |
Astrazeneca Lp
|
||||
Structure |
Download2D MOL |
||||
Formula |
C13H20N2O
|
||||
InChI |
InChI=1S/C13H20N2O/c1-4-9-14-11(3)13(16)15-12-8-6-5-7-10(12)2/h5-8,11,14H,4,9H2,1-3H3,(H,15,16)
|
||||
InChIKey |
MVFGUOIZUNYYSO-UHFFFAOYSA-N
|
||||
CAS Number |
CAS 721-50-6
|
||||
PubChem Compound ID | |||||
PubChem Substance ID |
9734, 95408, 5227596, 7847619, 7980380, 8153018, 10533889, 11336021, 11361260, 11364543, 11367105, 11369667, 11371923, 11375021, 11377829, 11462232, 11466227, 11467347, 11485134, 11485814, 11489365, 11490867, 11493006, 11495463, 15195949, 29223984, 37645318, 46505066, 47440311, 47515365, 47589045, 47662336, 47662337, 47959796, 48035180, 48185043, 48423995, 49698942, 49856374, 50111213, 50476259, 53790341, 85088898, 85171684, 85788442, 90341069, 92719754, 92729955, 103357947, 104253257
|
||||
SuperDrug ATC ID |
N01BB04
|
||||
SuperDrug CAS ID |
cas=000721506
|
||||
Target and Pathway | |||||
Target(s) | Sodium channel protein type 5 subunit alpha | Target Info | Blocker | [538082] | |
KEGG Pathway | Adrenergic signaling in cardiomyocytes | ||||
PathWhiz Pathway | Muscle/Heart Contraction | ||||
Reactome | Interaction between L1 and Ankyrins | ||||
References | |||||
Ref 538314 | FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (ANDA) 076290. | ||||
Ref 542296 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7276). | ||||
Ref 551871 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015 |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.